Your browser doesn't support javascript.
loading
Structural basis for inhibition of the Cation-chloride cotransporter NKCC1 by the diuretic drug bumetanide.
Zhao, Yongxiang; Roy, Kasturi; Vidossich, Pietro; Cancedda, Laura; De Vivo, Marco; Forbush, Biff; Cao, Erhu.
Afiliação
  • Zhao Y; Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, 84112-5650, USA.
  • Roy K; Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT, USA.
  • Vidossich P; Istituto Italiano di Tecnologia, Via Morego 30, 16163, Genova, Italy.
  • Cancedda L; Istituto Italiano di Tecnologia, Via Morego 30, 16163, Genova, Italy.
  • De Vivo M; Istituto Italiano di Tecnologia, Via Morego 30, 16163, Genova, Italy.
  • Forbush B; Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT, USA. biff.forbush@yale.edu.
  • Cao E; Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, 84112-5650, USA. Erhu.Cao@biochem.utah.edu.
Nat Commun ; 13(1): 2747, 2022 05 18.
Article em En | MEDLINE | ID: mdl-35585053
ABSTRACT
Cation-chloride cotransporters (CCCs) NKCC1 and NKCC2 catalyze electroneutral symport of 1 Na+, 1 K+, and 2 Cl- across cell membranes. NKCC1 mediates trans-epithelial Cl- secretion and regulates excitability of some neurons and NKCC2 is critical to renal salt reabsorption. Both transporters are inhibited by the so-called loop diuretics including bumetanide, and these drugs are a mainstay for treating edema and hypertension. Here, our single-particle electron cryo-microscopy structures supported by functional studies reveal an outward-facing conformation of NKCC1, showing bumetanide wedged into a pocket in the extracellular ion translocation pathway. Based on these and the previously published inward-facing structures, we define the translocation pathway and the conformational changes necessary for ion translocation. We also identify an NKCC1 dimer with separated transmembrane domains and extensive transmembrane and C-terminal domain interactions. We further define an N-terminal phosphoregulatory domain that interacts with the C-terminal domain, suggesting a mechanism whereby (de)phosphorylation regulates NKCC1 by tuning the strength of this domain association.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bumetanida / Simportadores Idioma: En Revista: Nat Commun Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bumetanida / Simportadores Idioma: En Revista: Nat Commun Ano de publicação: 2022 Tipo de documento: Article